Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was associated with a greater number of adverse events.
References:
Comparison of Dopamine and Norepinephrine in the Treatment of Shock. NEJM, 2010.
Image source: Wikipedia, public domain.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.